Effect of sodium intake on the excretion of urinary natriuretic factor in essential hypertensives. 1985

T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda

A simplified method for the determination of natriuretic factor in the urine as measured by digoxin-like substance was studied. Digoxin-like substance in the urine was estimated by RIA using anti-digoxin antibody after being extracted by reversed phase cartridge column but without gel filtration. The values found by radioimmunoassay (RIA) yielded a significant correlation with those of the inhibitory effect of Na-K-ATPase activity which was measured by biochemical assay as described by Hamlyn et al. Using this RIA method, the effect of salt intake on natriuretic factor in urine was studied in patients with essential hypertension. The natriuretic factor on a high sodium diet (NaCl 20 g/day for three days) increased approximately 1.5 times, as compared to those on a low sodium diet (NaCl 3 g/day) (p less than 0.05). The Natriuretic factor showed a positive correlation with urinary Na excretion (P less than 0.050) when the patients were placed on ad. lib. sodium diet. From these results, it is suggested that secretion of natriuretic factor in the urine might be regulated in part by salt intake.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D045283 Natriuretic Agents Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds. Chloriuretic Hormone,Natriuretic Agent,Natriuretic Factor,Natriuretic Hormone,Natriuretic Hormones,Chloriuretic Hormones,Natriuretic Effect,Natriuretic Effects,Natriuretic Factors,Agent, Natriuretic,Agents, Natriuretic,Effect, Natriuretic,Effects, Natriuretic,Factor, Natriuretic,Factors, Natriuretic,Hormone, Chloriuretic,Hormone, Natriuretic,Hormones, Chloriuretic,Hormones, Natriuretic

Related Publications

T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
March 1991, American journal of hypertension,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
April 1988, Journal of pharmacobio-dynamics,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
October 1987, Journal of hypertension,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
December 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
October 1986, Clinical science (London, England : 1979),
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
January 1987, Agents and actions. Supplements,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
December 1973, Klinische Wochenschrift,
T Morise, and I Miyamori, and S Hifumi, and S Okamoto, and M Ikeda, and Y Takeda, and H Koshida, and S Yasuhara, and R Takeda
March 1991, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!